Newsfeeds Archive - Page 393 of 461

1 minute read

FDA Approves scPharmaceuticals’ Self-Administered Med For Congestion in Chronic Heart Failure

October 10, 9:24 AM

The FDA has approved scPharmaceuticals Inc’s (NASDAQ:SCPH) Furoscix (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for…

SCPH

1 minute read

FDA Approves GSK’s Whooping Cough Vaccine During Pregnancy For Prevention In Infants

By Vandana Singh

October 10, 6:01 AM

The FDA has approved GSK Plc’s (NYSE:GSK) Boostrix vaccine during the third trimester of pregnancy to prevent whooping cough in infants…

GSK

1 minute read

HC Wainwright Initiates Aptorum On Upcoming “Innovative Pipeline”

By Vandana Singh

October 7, 3:40 PM

HC Wainwright initiated coverage on Aptorum Group Limited (NASDAQ:APM) with a Buy rating and a price target of $8. The analyst is…

APM

1 minute read

Pfizer’s Partner BioNTech Signs Research Pact With Australia

By Vandana Singh

October 7, 2:18 PM

Pfizer Inc’s (NYSE:PFE) COVID-19 partner BioNTech SE (NASDAQ:BNTX) will set up research and manufacturing centers in Australia. BioNTech and Australia’s Victoria state signed…

BNTX

1 minute read

Rebound In COVID-19 Symptoms After Pfizer’s Antiviral Pill Might Be Due To Stronger Immune Response

By Vandana Singh

October 7, 1:27 PM

Reports are circulating related to recurring COVID-19 symptoms after completing treatment and experiencing improvement after Pfizer Inc’s (NYSE:PFE) COVID-19 oral antiviral…

PFE

2 minute read

CVS Health Stock Falls After Change In Medicare Star Ratings

By Vandana Singh

October 7, 12:40 PM

The Centers for Medicare & Medicaid Services released its 2023 Star Ratings for Medicare Advantage (Medicare Part C) and Medicare Part D prescription drug plans.

CVS

1 minute read

PureTech Health Confirms ‘Possible’ Merger With Nektar Therapeutics

By Vandana Singh

October 7, 11:21 AM

PureTech Health plc (NASDAQ:PRTC) has confirmed that it is in talks about a possible tie-up with Nektar Therapeutics (NASDAQ:NKTR). In April, Nektar Therapeutics…

BMY

1 minute read

Alnylam’s Lumasiran Scores Expanded FDA Approval For Ultra Rare Genetic Disease

By Vandana Singh

October 7, 10:56 AM

The FDA approved a label expansion for Alnylam Pharmaceuticals Inc’s (NASDAQ:ALNY) for Oxlumo (lumasiran), an RNAi therapeutic administered via subcutaneous injection, now…

ALNY

1 minute read

BioMarin Lays Off 4% Of Its Workforce To ‘Simplify’ The Company

By Vandana Singh

October 7, 10:49 AM

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) will redesign the organization to better focus investments that advance its R&D pipeline, maximize recent commercial launch…

BMRN

1 minute read

Accolade Posts Narrower Quarterly Loss, Tightens Annual Sales Guidance

By Vandana Singh

October 7, 8:56 AM

Accolade Inc (NASDAQ:ACCD) reported Q2 FY23 sales of $87.6 million, up 20% Y/Y, beating the consensus of $82.86 million and…

ACCD